A 17-year-old boy with refractory psoriatic arthritis and alpha-1 antitrypsin deficiency who developed a syringotropic hypersensitivity reaction after 9 months of therapy with infliximab and leflunomide is described.
syringotropic hypersensitivity reaction
leflunomide
syringotropic hypersensitivity reaction
infliximab